Skip to main content
. 2018 Dec 11;91(24):e2265–e2275. doi: 10.1212/WNL.0000000000006645

Figure 1. Flowchart summarizing the ascertainment process of the patients with NMOSD.

Figure 1

Flowchart demonstrates the strategy of patient selection and validation in the Danish population of age 16 years and older. AQP4 = aquaporin-4; IPND = International Panel for Neuromyelitis Optica Diagnosis; MS = multiple sclerosis; NMOSD = neuromyelitis optica spectrum disorder.